The most commonly reported adverse effects are gastrointestinal in nature , affecting a significant proportion of patients, particularly during the initial weeks of treatment or following dose escalation
Contact your GP if you experience dark or concentrated urine with reduced output, foul-smelling urine with painful urination, sweet or fruity-smelling urine with excessive thirst or nausea (especially if diabetic), blood in urine, or fever with urinary symptoms
Mario Manunta
To put that in concrete terms: a person weighing 250 pounds could expect to lose roughly 20 to 22 pounds over that period
Liraglutide The injectable GLP-1 analogue, liraglutide (Victoza), is FDA approved for once-daily subcutaneous administration in combination with diet and exercise for the treatment of patients with T2DM
Use of these drugs has surged in recent years, and according to the CDC, about 1 in 12 American adults now has a GLP-1 prescription